title: [Cutaneous vasculitis during pergolide mesylate treatment].
authors.forename: J
authors.initials: J
authors.lastname: Serratrice
authors.forename: B
authors.initials: B
authors.lastname: Granel
authors.forename: P
authors.initials: P
authors.lastname: Disdier
authors.forename: P J
authors.initials: PJ
authors.lastname: Weiller
authors.forename: P
authors.initials: P
authors.lastname: Alcaraz
authors.forename: J P
authors.initials: JP
authors.lastname: Azulay
authors.forename: M J
authors.initials: MJ
authors.lastname: Jean-Pastor
mesh_terms: D000368:Aged; D018491:Dopamine Agonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010479:Pergolide / Q000009:adverse effects*; D011379:Prognosis; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced*
chemical_list: D018491:Dopamine Agonists; D010479:Pergolide